West Pharmaceutical Services (NYSE:WST) Coverage Initiated by Analysts at Citigroup

Analysts at Citigroup assumed coverage on shares of West Pharmaceutical Services (NYSE:WST – Get Free Report) in a research note issued on Wednesday,Briefing.com Automated Import reports. The brokerage set a “buy” rating and a $400.00 price target on the medical instruments supplier’s stock. Citigroup’s target price would suggest a potential upside of 20.24% from the […]

Leave a Reply

Your email address will not be published.

Previous post AngioDynamics (NASDAQ:ANGO) Updates FY 2025 Earnings Guidance
Next post Texas Roadhouse (NASDAQ:TXRH) Rating Lowered to “Hold” at Gordon Haskett